Status:
COMPLETED
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
Lead Sponsor:
ClinNovis GmbH
Conditions:
Rhinoconjunctivitis, Allergic
Eligibility:
All Genders
12+ years
Brief Summary
This study is a mere data collection without predefined intervention. Patients aged 12 years or older who suffer from allergic rhinitis induced by house dust mites, tree pollen or grass pollen and who...
Detailed Description
This study is a prospective, mulit-center data collection without predefined intervention. Patients aged 12 years or older who suffer from allergic rhinoconjunctivitis induced by house dust mites, tre...
Eligibility Criteria
Inclusion
- Patients aged 12 years or older who suffer from allergic rhinoconjunctivitis induced by house dust mites, tree pollen or grass pollen and who are treated exclusively with symptomatic medication
Exclusion
- Allergen-specific immunotherapy
Key Trial Info
Start Date :
October 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 25 2020
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04071249
Start Date
October 10 2019
End Date
August 25 2020
Last Update
August 26 2020
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Otorhinolaryngology practice
Aachen, Germany
2
Otorhinolaryngology practice
Bad Schönborn, Germany
3
Practice for lung and bronchial medicine
Bonn, Germany
4
Otorhinolaryngology practice
Dresden, Germany